Gohealth, Inc. (GOCO)

$10.01

-0.04

(-0.4%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on Gohealth, Inc.

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 132.03M → 276.69M (in $), with an average increase of 52.3% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -28.94M → -1.22M (in $), with an average increase of 935.7% per quarter

  • Vs AJG

    In the last 3 years, Arthur J Gallagher & Co. has given 64.9% return, outperforming this stock by 159.4%

Performance

  • $9.88
    $10.17
    $10.01
    downward going graph

    1.27%

    Downside

    Day's Volatility :2.82%

    Upside

    1.57%

    downward going graph
  • $7.05
    $22.85
    $10.01
    downward going graph

    29.57%

    Downside

    52 Weeks Volatility :69.15%

    Upside

    56.19%

    downward going graph

Returns

PeriodGohealth, Inc.Russel 2000Index (Russel 2000)
3 Months
-16.87%
0.0%
0.0%
6 Months
-20.36%
0.0%
0.0%
1 Year
30.86%
2.2%
2.2%
3 Years
-94.53%
-23.0%
-23.0%

Highlights

Market Capitalization
228.3M
Book Value
$23.94
Earnings Per Share (EPS)
-7.19
Wall Street Target Price
18.33
Profit Margin
-8.61%
Operating Margin TTM
9.06%
Return On Assets TTM
-2.73%
Return On Equity TTM
-28.91%
Revenue TTM
734.7M
Revenue Per Share TTM
79.07
Quarterly Revenue Growth YOY
298.8%
Gross Profit TTM
444.0M
EBITDA
29.0M
Diluted Eps TTM
-7.19
Quarterly Earnings Growth YOY
4.24
EPS Estimate Current Year
-5.39
EPS Estimate Next Year
-4.47
EPS Estimate Current Quarter
2.72
EPS Estimate Next Quarter
-1.0

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Gohealth, Inc.(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
1
Hold
2
2
3
Sell
00
00
4

Analyst Forecast

What analysts predicted

Upside of 83.12%

Current $10.01
Target $18.33

Company Financials

FY18Y/Y Change
Revenue
226.2M
-
Net Income
28.1M
-
Net Profit Margin
12.43%
-
FY19Y/Y Change
Revenue
539.5M
↑ 138.5%
Net Income
-41.1M
↓ 246.06%
Net Profit Margin
-7.61%
↓ 20.04%
FY20Y/Y Change
Revenue
877.4M
↑ 62.62%
Net Income
-97.2M
↑ 136.68%
Net Profit Margin
-11.08%
↓ 3.47%
FY21Y/Y Change
Revenue
1.1B
↑ 21.09%
Net Income
-534.2M
↑ 449.58%
Net Profit Margin
-50.28%
↓ 39.2%
FY22Y/Y Change
Revenue
631.7M
↓ 40.54%
Net Income
-376.4M
↓ 29.54%
Net Profit Margin
-59.59%
↓ 9.31%
FY23Y/Y Change
Revenue
734.7M
↑ 16.31%
Net Income
-63.3M
↓ 83.19%
Net Profit Margin
-8.61%
↑ 50.98%
Q3 FY22Q/Q Change
Revenue
133.1M
↓ 16.14%
Net Income
-40.2M
↓ 8.37%
Net Profit Margin
-30.18%
↓ 2.56%
Q4 FY22Q/Q Change
Revenue
69.4M
↓ 47.86%
Net Income
-150.7M
↑ 275.42%
Net Profit Margin
-217.28%
↓ 187.1%
Q1 FY23Q/Q Change
Revenue
183.2M
↑ 164.01%
Net Income
-22.5M
↓ 85.04%
Net Profit Margin
-12.31%
↑ 204.97%
Q2 FY23Q/Q Change
Revenue
142.8M
↓ 22.05%
Net Income
-28.9M
↑ 28.39%
Net Profit Margin
-20.27%
↓ 7.96%
Q3 FY23Q/Q Change
Revenue
132.0M
↓ 7.52%
Net Income
-23.9M
↓ 17.39%
Net Profit Margin
-18.11%
↑ 2.16%
Q4 FY23Q/Q Change
Revenue
276.7M
↑ 109.56%
Net Income
-1.2M
↓ 94.87%
Net Profit Margin
-0.44%
↑ 17.67%
FY18Y/Y Change
Total Assets
142.8M
-
Total Liabilities
329.5M
-
FY19Y/Y Change
Total Assets
1.6B
↑ 1021.76%
Total Liabilities
742.2M
↑ 125.24%
FY20Y/Y Change
Total Assets
2.1B
↑ 31.61%
Total Liabilities
709.6M
↓ 4.38%
FY21Y/Y Change
Total Assets
2.1B
↓ 1.89%
Total Liabilities
1.2B
↑ 65.77%
FY22Y/Y Change
Total Assets
1.7B
↓ 19.8%
Total Liabilities
1.1B
↓ 9.25%
FY23Y/Y Change
Total Assets
1.5B
↓ 9.63%
Total Liabilities
1.1B
↑ 2.47%
Q3 FY22Q/Q Change
Total Assets
2.0B
↑ 5.46%
Total Liabilities
1.3B
↑ 10.9%
Q4 FY22Q/Q Change
Total Assets
1.7B
↓ 17.1%
Total Liabilities
1.1B
↓ 15.54%
Q1 FY23Q/Q Change
Total Assets
1.5B
↓ 6.98%
Total Liabilities
970.9M
↓ 9.06%
Q2 FY23Q/Q Change
Total Assets
1.5B
↓ 3.97%
Total Liabilities
972.2M
↑ 0.14%
Q3 FY23Q/Q Change
Total Assets
1.4B
↓ 3.03%
Total Liabilities
983.5M
↑ 1.16%
Q4 FY23Q/Q Change
Total Assets
1.5B
↑ 4.32%
Total Liabilities
1.1B
↑ 11.23%
FY18Y/Y Change
Operating Cash Flow
5.4M
-
Investing Cash Flow
-6.2M
-
Financing Cash Flow
63.0K
-
FY19Y/Y Change
Operating Cash Flow
-3.0K
↓ 100.06%
Investing Cash Flow
-815.6M
↑ 13118.91%
Financing Cash Flow
827.4M
↑ 1313280.95%
FY20Y/Y Change
Operating Cash Flow
-114.2M
↑ 3807133.33%
Investing Cash Flow
-14.5M
↓ 98.22%
Financing Cash Flow
260.7M
↓ 68.5%
FY21Y/Y Change
Operating Cash Flow
-299.0M
↑ 161.79%
Investing Cash Flow
-19.8M
↑ 36.34%
Financing Cash Flow
259.1M
↓ 0.6%
FY22Y/Y Change
Operating Cash Flow
60.9M
↓ 120.37%
Investing Cash Flow
-13.5M
↓ 31.76%
Financing Cash Flow
-115.1M
↓ 144.41%
Q3 FY22Q/Q Change
Operating Cash Flow
95.5M
↓ 298.56%
Investing Cash Flow
-2.4M
↓ 33.41%
Financing Cash Flow
46.0M
↓ 3487.56%
Q4 FY22Q/Q Change
Operating Cash Flow
-41.0M
↓ 142.92%
Investing Cash Flow
-1.4M
↓ 41.92%
Financing Cash Flow
-156.6M
↓ 440.39%
Q1 FY23Q/Q Change
Operating Cash Flow
20.5M
↓ 149.95%
Investing Cash Flow
-2.2M
↑ 57.2%
Financing Cash Flow
-2.4M
↓ 98.47%
Q2 FY23Q/Q Change
Operating Cash Flow
10.9M
↓ 46.97%
Investing Cash Flow
-2.4M
↑ 9.34%
Financing Cash Flow
-15.4M
↑ 543.68%

Technicals Summary

Sell

Neutral

Buy

Gohealth, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gohealth, Inc.
Gohealth, Inc.
-5.81%
-20.36%
30.86%
-94.53%
-96.56%
Willis Towers Watson Plc
Willis Towers Watson Plc
-3.52%
27.31%
11.23%
14.35%
45.68%
Marsh & Mclennan Companies, Inc.
Marsh & Mclennan Companies, Inc.
-1.19%
7.39%
14.0%
57.98%
114.6%
Arthur J Gallagher & Co.
Arthur J Gallagher & Co.
-3.57%
3.01%
15.27%
74.34%
184.8%
Aon Plc
Aon Plc
-6.39%
-3.4%
-5.66%
34.55%
71.41%
Brown & Brown Inc.
Brown & Brown Inc.
-4.96%
18.99%
30.74%
64.92%
159.25%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gohealth, Inc.
Gohealth, Inc.
NA
NA
NA
-5.39
-0.29
-0.03
NA
23.94
Willis Towers Watson Plc
Willis Towers Watson Plc
26.53
26.53
1.12
16.3
0.11
0.04
0.01
92.84
Marsh & Mclennan Companies, Inc.
Marsh & Mclennan Companies, Inc.
25.57
25.57
2.43
8.72
0.33
0.09
0.01
25.21
Arthur J Gallagher & Co.
Arthur J Gallagher & Co.
53.46
53.46
2.09
10.12
0.1
0.03
0.01
49.73
Aon Plc
Aon Plc
24.88
24.88
1.52
16.2
0.58
0.08
0.01
-4.16
Brown & Brown Inc.
Brown & Brown Inc.
25.6
25.6
4.41
3.51
0.17
0.06
0.01
20.27
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gohealth, Inc.
Gohealth, Inc.
Buy
$228.3M
-96.56%
NA
-8.61%
Willis Towers Watson Plc
Willis Towers Watson Plc
Hold
$27.0B
45.68%
26.53
11.13%
Marsh & Mclennan Companies, Inc.
Marsh & Mclennan Companies, Inc.
Hold
$99.4B
114.6%
25.57
16.84%
Arthur J Gallagher & Co.
Arthur J Gallagher & Co.
Buy
$51.9B
184.8%
53.46
10.14%
Aon Plc
Aon Plc
Hold
$61.7B
71.41%
24.88
19.17%
Brown & Brown Inc.
Brown & Brown Inc.
Hold
$23.7B
159.25%
25.6
21.34%

Institutional Holdings

  • Centerbridge Partners, L.P.

    43.75%

  • BlackRock Inc

    3.08%

  • Vanguard Group Inc

    2.10%

  • CI Private Wealth LLC

    1.72%

  • Geode Capital Management, LLC

    0.95%

  • Blue Owl Capital Holdings LP

    0.87%

Corporate Announcements

  • Gohealth, Inc. Earnings

    Gohealth, Inc.’s price-to-earnings ratio stands at None

    Read More

Company Information

Organization
Gohealth, Inc.
Employees
2530
CEO
Mr. Brandon M. Cruz
Industry
Finance

Discover More

FAQs